Hydrochlorothiazide Tablet
Product Images NDC 51655-506

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 51655-506). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 506 26 Master Bottle Label Approval Rev A 05 20)

Label (51655 506 26 Master Bottle Label Approval Rev A 05 20)
Hydrochlorothiazide Tablets USP 50 mg label for a 90-tablet bottle, oral dosage form. The label includes storage instructions at 20°C to 25°C, a caution to keep out of reach of children, and to keep container tightly closed. It also contains NDC 51655-506-26 and is labeled by Northwind Health Company, LLC.*
FDA Label Image

Structure (Hydrochlorothiazide Str)

Structure (Hydrochlorothiazide Str)
Chemical structure of hydrochlorothiazide, showing its molecular configuration with a chlorinated benzothiadiazine ring and sulfonamide groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.